Global burden of noncommunicable diseases attributable to high fasting plasma glucose
Global burden of noncommunicable diseases attributable to high fasting plasma glucose
复制标题
高空腹血糖导致的非传染性疾病的全球负担
DOI：
10.1111/1753-0407.13072
复制
发表时间：
2020-05
影响因子：
4.5
通讯作者：
Pengfei Shan
中科院分区：
文献类型：
--
作者：
Lingxia Ye;Jingya Xu;Tianyue Zhang;Xiling Lin;Xiaowen Pan;Wenheng Zeng;Yuezhong Ren;Pengfei Shan
背景：高血糖是一个主要的公共卫生问题。了解由高空腹血糖（HFPG）引起的全球非传染性疾病（NCDs）负担的最新趋势对于确定研究重点和规划卫生政策至关重要。方法：这是一项比较疾病负担的研究。我们从2017年全球疾病负担研究中获得了HFPG导致的非传染性疾病死亡和残疾调整生命年（DALYs）的全球、地区和国家数据，按时间、年龄、性别、地点和具体原因对死亡和DALYs进行了二次分析，并分析了它们之间的关联。结果2017年，非传染性疾病中有639万例死亡和16636万例DALYs可归因于HFPG，分别占总死亡人数和DALYs的15.6%和10.7%。负荷率随时间的增加而降低，随年龄的增长而增加，其中男性负荷率明显高于男性。社会人口指数（SDI）与疾病负担呈负相关，与性别差异和性别比例的男性优势呈正相关。结论自1990年以来，HFPG导致的非传染性疾病负担显著增加，且各地区差异很大。需要作出更大的努力来预防和控制高血糖，特别是在欠发达国家和男性中。
BackgroundHyperglycemia is a major public health concern. An understanding of the latest trends of the global burden of noncommunicable diseases (NCDs) by high fasting plasma glucose (HFPG) is critical for determining research priorities and planning health policy.MethodsThis is a comparative burden‐of‐disease study. We obtained global, regional, and national data on deaths and disability‐adjusted life years (DALYs) of NCDs attributable to HFPG from the Global Burden of Disease Study 2017, performed a secondary analysis of deaths and DALYs by time, age, gender, location, and specific causes, and analyzed their associations.ResultsIn 2017, 6.39 million deaths and 166.36 million DALYs from NCDs were attributable to HFPG, accounting for 15.6% and 10.7% of all deaths and DALYs, respectively. The burden's rate decreased with time, increased with age and was significantly higher in males. A negative association was found between the sociodemographic index (SDI) and disease burden, and a positive association was found between SDI and male superiority by gender difference and gender ratio.ConclusionsThe burden of NCDs attributable to HFPG has increased significantly since 1990 and varied widely across regions. Greater efforts are needed to prevent and control hyperglycemia, especially in less developed countries and among males.
登录
查看更多内容
DOI：
10.1016/s0140-6736(18)31694-5
发表时间：
2018-11-10
期刊：
Lancet (London, England)
影响因子：
--
作者：
Foreman KJ;Marquez N;Dolgert A;Fukutaki K;Fullman N;McGaughey M;Pletcher MA;Smith AE;Tang K;Yuan CW;Brown JC;Friedman J;He J;Heuton KR;Holmberg M;Patel DJ;Reidy P;Carter A;Cercy K;Chapin A;Douwes-Schultz D;Frank T;Goettsch F;Liu PY;Nandakumar V;Reitsma MB;Reuter V;Sadat N;Sorensen RJD;Srinivasan V;Updike RL;York H;Lopez AD;Lozano R;Lim SS;Mokdad AH;Vollset SE;Murray CJL
通讯作者：
Murray CJL
DOI：
10.1016/s0140-6736(18)32225-6
发表时间：
2018-11-10
期刊：
Lancet (London, England)
影响因子：
--
作者：
GBD 2017 Risk Factor Collaborators
通讯作者：
GBD 2017 Risk Factor Collaborators
影响因子：
30.8
作者：
通讯作者：
--
影响因子：
3.5
作者：
Jae-Jeong Yang;Hyung-Suk Yoon;Sang Ah Lee;Jin Y. Choi;Minkyo Song;Sungshik Han;Jong Koo Lee;Daeshik Kang
通讯作者：
Jae-Jeong Yang;Hyung-Suk Yoon;Sang Ah Lee;Jin Y. Choi;Minkyo Song;Sungshik Han;Jong Koo Lee;Daeshik Kang
影响因子：
2.9
作者：
Park, Soojin;Shin, Weon-Sun
通讯作者：
Shin, Weon-Sun